Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > new tweet from SBM

<< Previous

Bullboard Posts

Next >>

Comment by MirrorWorldManon Jun 21, 2022 12:09pm

182 Views

Post# 34771523

RE:RE:RE:RE:RE:RE:RE:RE:new tweet from SBM

It is difficult to understand why Howie wants to still to business with Wannabang, Afterall, it took 10 years to do anything with our SGLT2 and then that company dumped us for generics. They must of know of the pending favourable generic government policies and strung us along. Now they are saying we go to pets. Whats stopping anyone from using a generic SGLT2 in pets as well. I would dump them as they dump us. Businesses are moving out of China now into more favourable EU manufacturing enviroments and Howie wants to continue with a company proven to abrasive to our needs? Crazy

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario